Related references
Note: Only part of the references are listed.Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails
Shicheng Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele
Kenichiro Iwami et al.
CYTOTHERAPY (2012)
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2011)
IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype
Jana Albrecht et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
Ling Zhang et al.
MOLECULAR THERAPY (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hypoxia Potentiates Glioma-Mediated Immunosuppression
Jun Wei et al.
PLOS ONE (2011)
The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
Shoba Amarnath et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
John C. Markley et al.
BLOOD (2010)
Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
Jenny J. Hong et al.
CLINICAL CANCER RESEARCH (2010)
Features of responding T cells in cancer and chronic infection
Peter S. Kim et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
CD8+T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival
Isaac Yang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
A Simplified Method for the Clinical-scale Generation of Central Memory-like CD8+T Cells After Transduction With Lentiviral Vectors Encoding Antitumor Antigen T-cell Receptors
Shicheng Yang et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
Jun Wei et al.
MOLECULAR CANCER THERAPEUTICS (2010)
IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46
Maya Eisenring et al.
NATURE IMMUNOLOGY (2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
γc deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors
Helene Decaluwe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Stem cell-like plasticity of naive and distinct memory CD8+ T cell subsets
Christian Stemberger et al.
SEMINARS IN IMMUNOLOGY (2009)
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2008)
Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansion
Zhenmin Ye et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Priming of naive CD8+T cells in the presence of IL-12 selectively enhances the survival of CD8(+)CD62L(hi) cells and results in superior anti-tumor activity in a tolerogenic murine model
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation
Jee-Boong Lee et al.
INTERNATIONAL IMMUNOLOGY (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
CD8(+) T-cell memory in tumor immunology and immunotherapy
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2006)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Regulation of membrane metalloproteolytic cleavage of L-selectin (CD62L) by the epidermal growth factor domain
LC Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
RNA-transfected dendritic cells in cancer immunotherapy
DA Mitchell et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
